OPKO Health, Inc. Increase (Decrease) in Accrued Liabilities
OPKO Health, Inc. (OPK) reported Increase (Decrease) in Accrued Liabilities of $9.55 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-05-03
- OPKO Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2023-03-31 was $9.55M.
- OPKO Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was -$8.15M, a 125.50% decline year-over-year.
- OPKO Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was -$12.65M.
- OPKO Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was -$33.80M.
- OPKO Health, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$90.78M.
- OPKO Health, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was -$33.72M, a 141.21% decline from fiscal 2020.
- OPKO Health, Inc. increase (decrease) in accrued liabilities for fiscal 2020 was $81.83M, a 10610.47% increase from fiscal 2019.
- OPKO Health, Inc. increase (decrease) in accrued liabilities for fiscal 2019 was $764.00K, a 55.45% decline from fiscal 2018.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | $9.55M 10-Q · filed 2023-05-03 | $1.40M derived: sum of 2 quarters · filed 2023-05-03 | -$11.26M derived: sum of 3 quarters · filed 2023-05-03 | -$45.06M derived: sum of 4 quarters · filed 2023-05-03 | ||||
| 2022-12-31 | -$8.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$20.80M derived: sum of 2 quarters · filed 2023-02-27 | -$54.60M derived: sum of 3 quarters · filed 2023-02-27 | -$90.78M 10-K · filed 2023-02-27 | ||||
| 2022-09-30 | -$12.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$46.45M derived: sum of 2 quarters · filed 2022-11-08 | -$82.63M 10-Q · filed 2022-11-08 | -$50.67M derived: sum of 4 quarters · filed 2023-05-03 | ||||
| 2022-06-30 | -$33.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$69.98M 10-Q · filed 2022-08-04 | -$38.01M derived: sum of 3 quarters · filed 2023-05-03 | -$54.54M derived: sum of 4 quarters · filed 2023-05-03 | ||||
| 2022-03-31 | -$36.18M 10-Q · filed 2023-05-03 | -$4.21M derived: sum of 2 quarters · filed 2023-05-03 | -$20.74M derived: sum of 3 quarters · filed 2023-05-03 | -$42.77M derived: sum of 4 quarters · filed 2023-05-03 | ||||
| 2021-12-31 | $31.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $15.44M derived: sum of 2 quarters · filed 2023-02-27 | -$6.60M derived: sum of 3 quarters · filed 2023-02-27 | -$33.72M 10-K · filed 2023-02-27 | ||||
| 2021-09-30 | -$16.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$38.56M derived: sum of 2 quarters · filed 2022-11-08 | -$65.69M 10-Q · filed 2022-11-08 | -$72.85M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | -$22.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$49.16M 10-Q · filed 2022-08-04 | -$49.16M 10-Q · filed 2021-07-29 | -$56.32M derived: sum of 3 quarters · filed 2023-02-27 | -$14.92M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-03-31 | -$27.13M 10-Q · filed 2022-05-09 | -$34.29M derived: sum of 2 quarters · filed 2023-02-27 | $7.12M derived: sum of 3 quarters · filed 2023-02-27 | $50.85M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | -$7.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $34.24M derived: sum of 2 quarters · filed 2023-02-27 | $77.98M derived: sum of 3 quarters · filed 2023-02-27 | $81.83M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $41.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $85.14M derived: sum of 2 quarters · filed 2021-10-28 | $88.99M 10-Q · filed 2021-10-28 | $89.99M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $43.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $47.59M 10-Q · filed 2021-07-29 | $48.59M derived: sum of 3 quarters · filed 2022-03-01 | $46.25M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $3.85M 10-Q · filed 2021-04-28 | $4.85M derived: sum of 2 quarters · filed 2022-03-01 | $2.52M derived: sum of 3 quarters · filed 2022-03-01 | -$7.64M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$1.33M derived: sum of 2 quarters · filed 2022-03-01 | -$11.49M derived: sum of 3 quarters · filed 2022-03-01 | $764.00K 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$12.49M derived: sum of 2 quarters · filed 2020-10-29 | -$238.00K 10-Q · filed 2020-10-29 | $6.04M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-06-30 | -$10.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $2.10M 10-Q · filed 2020-07-31 | $8.37M derived: sum of 3 quarters · filed 2021-02-18 | $19.63M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-03-31 | $12.25M 10-Q · filed 2020-05-06 | $18.52M derived: sum of 2 quarters · filed 2021-02-18 | $29.79M derived: sum of 3 quarters · filed 2021-02-18 | $22.79M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2018-12-31 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $17.54M derived: sum of 2 quarters · filed 2021-02-18 | $10.54M derived: sum of 3 quarters · filed 2021-02-18 | $1.72M 10-K · filed 2021-02-18 | ||||
| 2018-09-30 | $11.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $4.27M derived: sum of 2 quarters · filed 2019-11-05 | -$4.56M 10-Q · filed 2019-11-05 | $37.77M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | -$6.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$15.82M 10-Q · filed 2019-08-07 | $26.51M derived: sum of 3 quarters · filed 2020-03-02 | $18.46M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$8.83M 10-Q · filed 2019-05-08 | $33.50M derived: sum of 2 quarters · filed 2020-03-02 | $25.45M derived: sum of 3 quarters · filed 2020-03-02 | $37.64M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $42.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $34.28M derived: sum of 2 quarters · filed 2020-03-02 | $46.47M derived: sum of 3 quarters · filed 2020-03-02 | $30.44M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | -$8.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $4.13M derived: sum of 2 quarters · filed 2018-11-09 | -$11.89M 10-Q · filed 2018-11-09 | $20.13M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $12.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$3.84M 10-Q · filed 2018-08-07 | $28.18M derived: sum of 3 quarters · filed 2019-03-01 | $30.75M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | -$16.02M 10-Q · filed 2018-05-08 | $16.00M derived: sum of 2 quarters · filed 2019-03-01 | $18.56M derived: sum of 3 quarters · filed 2019-03-01 | $38.89M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $32.02M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $34.58M derived: sum of 2 quarters · filed 2019-03-01 | $54.91M derived: sum of 3 quarters · filed 2019-03-01 | $68.04M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $22.89M derived: sum of 2 quarters · filed 2017-11-08 | $36.02M 10-Q · filed 2017-11-08 | $8.73M derived: sum of 4 quarters · filed 2019-01-29 | ||||
| 2016-06-30 | $20.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $33.45M 10-Q · filed 2017-08-08 | $6.17M derived: sum of 3 quarters · filed 2019-01-29 | $40.21M derived: sum of 4 quarters · filed 2019-01-29 | ||||
| 2016-03-31 | $13.13M 10-Q · filed 2017-05-10 | -$14.16M derived: sum of 2 quarters · filed 2019-01-29 | $19.89M derived: sum of 3 quarters · filed 2019-01-29 | $18.21M derived: sum of 4 quarters · filed 2019-01-29 | ||||
| 2015-12-31 | -$27.29M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $6.76M derived: sum of 2 quarters · filed 2019-01-29 | $5.09M derived: sum of 3 quarters · filed 2019-01-29 | $9.50M 8-K · filed 2019-01-29 | ||||
| 2015-09-30 | $34.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $32.38M derived: sum of 2 quarters · filed 2016-11-07 | $36.79M 10-Q · filed 2016-11-07 | $43.39M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | -$1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $2.74M 10-Q · filed 2016-08-08 | $9.34M derived: sum of 3 quarters · filed 2017-03-01 | $10.49M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $4.41M 10-Q · filed 2016-05-09 | $11.01M derived: sum of 2 quarters · filed 2017-03-01 | $12.16M derived: sum of 3 quarters · filed 2017-03-01 | $10.87M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $7.75M derived: sum of 2 quarters · filed 2017-03-01 | $6.46M derived: sum of 3 quarters · filed 2017-03-01 | $4.93M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$140.00K derived: sum of 2 quarters · filed 2015-11-09 | -$1.67M 10-Q · filed 2015-11-09 | -$7.61M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$2.82M 10-Q · filed 2015-08-05 | -$3.66M 10-Q · filed 2014-08-11 | -$8.76M derived: sum of 3 quarters · filed 2016-02-29 | -$6.42M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$1.53M 10-Q · filed 2015-05-11 | -$8.01M 10-Q · filed 2014-05-09 | -$7.47M derived: sum of 2 quarters · filed 2016-02-29 | -$5.13M derived: sum of 3 quarters · filed 2016-02-29 | $2.44M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$5.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$3.60M derived: sum of 2 quarters · filed 2016-02-29 | $3.96M derived: sum of 3 quarters · filed 2016-02-29 | $3.52M 10-K · filed 2016-02-29 | $779.00K 10-K · filed 2014-03-03 | |||
| 2013-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $9.91M derived: sum of 2 quarters · filed 2014-11-07 | $9.47M 10-Q · filed 2014-11-07 | $6.93M 10-Q · filed 2013-11-12 | $10.69M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | $7.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $7.13M 10-Q · filed 2014-08-11 | $4.59M 10-Q · filed 2013-08-09 | $8.35M derived: sum of 3 quarters · filed 2015-02-27 | $8.89M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | -$440.00K 10-Q · filed 2014-05-09 | $779.00K derived: sum of 2 quarters · filed 2015-02-27 | $1.32M derived: sum of 3 quarters · filed 2015-02-27 | -$15.00K derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $1.76M derived: sum of 2 quarters · filed 2015-02-27 | $425.00K derived: sum of 3 quarters · filed 2015-02-27 | $1.68M 10-K · filed 2015-02-27 | $2.36M 10-K · filed 2013-03-18 | |||
| 2012-09-30 | $546.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$794.00K derived: sum of 2 quarters · filed 2013-11-12 | $459.00K 10-Q · filed 2013-11-12 | -$414.00K derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2012-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$87.00K 10-Q · filed 2013-08-09 | -$960.00K derived: sum of 3 quarters · filed 2014-03-03 | $690.00K derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2012-03-31 | $1.25M 10-Q · filed 2013-05-10 | $380.00K derived: sum of 2 quarters · filed 2014-03-03 | $2.03M derived: sum of 3 quarters · filed 2014-03-03 | $1.57M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2011-12-31 | -$873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $777.00K derived: sum of 2 quarters · filed 2014-03-03 | $319.00K derived: sum of 3 quarters · filed 2014-03-03 | -$21.00K 10-K · filed 2014-03-03 | -$412.00K 10-K · filed 2012-03-15 | |||
| 2011-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.19M derived: sum of 2 quarters · filed 2012-11-09 | $852.00K 10-Q · filed 2012-11-09 | $1.07M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | -$458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$798.00K 10-Q · filed 2012-08-09 | -$903.00K 10-Q · filed 2011-08-08 | -$577.00K derived: sum of 3 quarters · filed 2013-03-18 | -$1.35M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-03-31 | -$340.00K 10-Q · filed 2012-05-10 | -$119.00K derived: sum of 2 quarters · filed 2013-03-18 | -$890.00K derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$550.00K derived: sum of 2 quarters · filed 2013-03-18 | -$3.51M 10-K · filed 2013-03-18 | -$3.86M 10-K · filed 2012-03-15 | ||||
| 2010-09-30 | -$771.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$3.73M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | -$2.96M 10-Q · filed 2011-08-08 | |||||||
| 2009-12-31 | -$829.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |